Immediate and long-term effects of an electronic medication management system on paediatric prescribing errors: A stepped-wedge cluster randomised controlled trial with one-year follow-up
Preprint
- 29 September 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Objectives: To assess the immediate (first 70 days of use) and long-term (one-year) effectiveness of an electronic medication management (eMM) system to reduce prescribing errors, and their potential and actual harm in paediatrics. Design: A stepped-wedge cluster randomised controlled trial (SWCRCT) over 11 weeks (April–July 2016): 8 clusters randomised for eMM implementation. All medication orders during the trial and for a random sample of medication orders one-year post-eMM implementation (June–September 2017) were reviewed. Clinical prescribing errors were rated for the severity of potential harm on a 5-point scale. Errors (score ≥3 ie potential adverse drug events [ADEs]) identified in the SWCRCT were assessed for actual harm (actual ADEs). Setting: A 310-bed paediatric referral hospital in Sydney, Australia. Participants: Inpatients. Control and Intervention: Paper medication charts (control); eMM (intervention). Primary outcomes: clinical prescribing errors, potential ADEs. Secondary outcomes: procedural errors, clinical prescribing errors for high-risk medications and by error type, clinical errors associated with actual harm (ADEs) during the SWCRCT. Results: 35,260 medication orders for 4,821 patients were reviewed. In the first 70 days of eMM use there was no significant change in overall clinical prescribing error rates (Incident Rate Ratio [IRR] 1.05[95%CI 0.92-1.21], p=0.45). However, potential ADEs significantly increased by 62% (IRR 1.62[95%CI 1.28-2.04], pDiscussion: This is the first randomised controlled trial of the effects of eMM on paediatric prescribing errors. The first 70 days of use showed no overall improvement and an increase in some categories of errors. The results suggest immediate risks to medication safety during the early periods of system use. A year after implementation error rates significantly declined from baseline suggesting long-term benefits to safety. Optimisation of eMM should focus on features to reduce dose errors due to their high frequency and greater capacity to cause harm.Keywords
All Related Versions
- Version 1, 2022-09-29, Research Square
- Published version: npj Digital Medicine, 5 (1), 1.
This publication has 29 references indexed in Scilit:
- The safety of electronic prescribing: manifestations, mechanisms, and rates of system-related errors associated with two commercial systems in hospitalsJournal of the American Medical Informatics Association, 2013
- The effect of a computerized pediatric dosing decision support system on pediatric dosing errorsJournal of Food and Drug Analysis, 2013
- Electronic Prescribing in Pediatrics: Toward Safer and More Effective Medication ManagementPediatrics, 2013
- Tenfold Medication Errors: 5 Years’ Experience at a University-Affiliated Pediatric HospitalPediatrics, 2012
- Reviewing the impact of computerized provider order entry on clinical outcomes: The quality of systematic reviewsInternational Journal of Medical Informatics, 2012
- The pros and cons of electronic prescribing for childrenArchives of Disease in Childhood, 2011
- The Impact of Computerized Provider Order Entry Systems on Inpatient Clinical Workflow: A Literature ReviewJournal of the American Medical Informatics Association, 2009
- Impact of Computerized Prescriber Order Entry on the Incidence of Adverse Drug Events in Pediatric InpatientsPediatrics, 2007
- Design and analysis of stepped wedge cluster randomized trialsContemporary Clinical Trials, 2007
- Medication Errors Related to Computerized Order Entry for ChildrenPediatrics, 2006